Anna Palmer Durbin MD

Associate Professor

1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001

Dr. Durbin is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Durbin's full profile Already have an account?

Education & Training

Detroit Medical Center/Wayne State UniversityFellowship, Infectious Disease, 1991 - 1994
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 1987 - 1991
Wayne State University School of MedicineClass of 1987

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MD State Medical License 1994 - 2026
MI State Medical License 1983 - 2015
DC State Medical License 2006 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults Start of enrollment: 2004 Sep 01
Completed
Phase 1
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults Start of enrollment: 2005 Jan 01
Completed
Phase 1
Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults Start of enrollment: 2005 Feb 01
Completed
Phase 1

Publications & Presentations

PubMed

Corrigendum to 'Localized Inflammation in Dengue Vaccine-Induced Skin Rash Is Not Associated with Continuous Presence of Dengue Virus Genome' Journal of Investigative ...
Camilla Strother, Nicole Bouffard, Olha Smolynets, Nancy R Graham, Evan A Elko
The Journal of Investigative Dermatology. 2026-05-01
3 citations
Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine.
Esper G Kallás, José A Moreira, Elizabeth G Patiño, Patricia Emilia Braga, Juliana C V Tenório
Nature Medicine. 2026-04-01
Enhancing, controlling, and sterilizing dengue immunity and the development of broadly protective responses.
Camila D Odio, Rosemary A Aogo, Saba Firdous, Charlie Voirin, Silvia Blanco-Rivera
Medrxiv. 2026-03-27

Press Mentions

FDA Panel Backs First-of-Its-Kind Flu Vaccine Using mRNA TechnologyJune 18th, 2026
Unpacking the FDA’s Black Friday Vaccine MemoDecember 4th, 2025
Vaccines Do More Than Prevent DiseaseNovember 4th, 2025

Grant Support

Mechanisms of Protection and Durability for a Live Attenuated Tetravalent Dengue VaccineUNIVERSITY OF VERMONT & ST AGRIC COLLEGE2019–2029
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, DOSE-RANGING STUDY TO COMPARE THE SAFETY AND EFFICACY OF 3 DOSE LEVELS OF AV-1 IN HEALTHY ADULTS CHALLENGED WITH A CONTROLLED HUMAN INFECTION SJOHNS HOPKINS UNIVERSITY2023–2025